A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral Neuropathy

A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral Neuropathy

Conditions: Painful Diabetic Neuropathy; Diabetes Mellitus
Interventions: Drug: Active: WST-057 4mL (146 mg pirenzepine free base monohydrate) topical solution; Drug: Placebo: WST-057 4mL topical solution
Sponsors: WinSanTor, Inc; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Eastern Virginia Medical School
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 29, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments